| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CCT036477 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-16 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | 0.34 | 8e-13 |
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-11 |
| mRNA | navitoclax:sorafenib (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.21 | 3e-09 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.2 | 9e-09 |
| mRNA | ABT-737 | CTRPv2 | pan-cancer | AAC | 0.21 | 2e-08 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.25 | 2e-08 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | 0.2 | 4e-08 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.21 | 6e-08 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.33 | 8e-07 |